Immix Biopharma, Inc.
US ˙ NasdaqCM ˙ US45258H1068

SecurityIMMX / Immix Biopharma, Inc.
InsiderIlya M Rachman
This page shows the track record and history of Rachman Ilya M insider trades in Immix Biopharma, Inc.. The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company. It is illegal for insiders to make trades in their companies based on material, non-public information ("MNPI"). This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4.
Insider Purchases - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made by Ilya M Rachman in IMMX / Immix Biopharma, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
2025-09-17 2,500 2.0200 2,500 2.0200 5,050 2 2.1900 425 8.42
2025-06-18 2,178 2.2950 2,178 2.2950 4,999
2024-06-07 2,600 2.1300 2,600 2.1300 5,538
2024-06-04 3,300 1.8091 3,300 1.8091 5,970
2024-05-14 4,300 2.2465 4,300 2.2465 9,660
2022-11-14 4,050 1.0190 4,050 1.0190 4,127
2022-11-14 1,000 0.9500 1,000 0.9500 950
2022-11-14 150 0.9900 150 0.9900 148
2021-12-20 2,500 5.0000 2,500 5.0000 12,500

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

IMMX / Immix Biopharma, Inc. Insider Trades
Insider Sales - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made by Ilya M Rachman in IMMX / Immix Biopharma, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

IMMX / Immix Biopharma, Inc. Insider Trades
Insider Transaction History
File
Date
Trade
Date
Form Insider Ticker Security Title Code 10b5-1 Direct Exercise
Price
Unit
Price
Units
Changed
Value
Changed (1K)
Remaining
Options
Remaining
Shares
2025-09-17 2025-09-17 4 Rachman Ilya M IMMX Common Stock P - Purchase D 2.0200 2,500 5 1,140,937
2025-06-20 2025-06-18 4 Rachman Ilya M IMMX Common Stock P - Purchase D 2.2950 2,178 5 1,138,437
2024-06-10 2024-06-07 4 Rachman Ilya M IMMX Common Stock P - Purchase D 2.1300 2,600 6 1,136,259
2024-06-05 2024-06-04 4 Rachman Ilya M IMMX Common Stock P - Purchase D 1.8091 3,300 6 1,133,659
2024-05-20 2024-05-20 4 Rachman Ilya M IMMX Common Stock A - Award D 218,359 1,130,359
2024-05-14 2024-05-14 4 Rachman Ilya M IMMX Common Stock P - Purchase D 2.2465 4,300 10 912,000
2022-11-15 2022-11-14 4 Rachman Ilya M IMMX Common Stock P - Purchase D 0.9900 150 0 907,700
2022-11-15 2022-11-14 4 Rachman Ilya M IMMX Common Stock P - Purchase D 0.9500 1,000 1 907,550
2022-11-15 2022-11-14 4 Rachman Ilya M IMMX Common Stock P - Purchase D 1.0190 4,050 4 906,550
2021-12-20 2021-12-20 4 Rachman Ilya M IMMX Common Stock P - Purchase D 5.0000 2,500 12 902,500
2021-12-15 3 Rachman Ilya M IMMX Common stock D 900,000
P
Köp på öppna marknaden eller privat köp av icke-derivatsäkerhet
S
Köp på öppna marknaden eller privat försäljning av icke-derivatsäkerhet
A
Bevilja, tilldelning eller annat förvärv av värdepapper från företaget (såsom en option)
C
Omvandling av derivat
D
Försäljning eller överföring av värdepapper tillbaka til företaget
F
Betalning av lösenpris eller skatteskuld med del av värdepapper som erhållits från bolaget
G
Överlåtelse av värdepapper från eller till insidern
K
Aktieswappar och liknande säkringsaffärer
M
Utövande eller omvandling av derivatsäkerhet som erhållits från företaget (som en option)
V
En transaktion friviligt rapporterad på schema 4
J
Andra (med en fotnot som beskriver transaktionen)